Famciclovir as antiviral prophylaxis in laser resurfacing procedures

Plastic and Reconstructive Surgery

Volumn 104, Issue 4, 1999, Pages 1103-1108

  Wall, Simeon H ^a,b   Ramey, Stephen J ^a   Wall, Forrest ^a  

^a Plastic Surgery LLP   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; FAMCICLOVIR; NUCLEOSIDE ANALOG;

ADOLESCENT; ADULT; AGED; ARTICLE; CARBON DIOXIDE LASER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FACE SURGERY; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROPHYLAXIS; VIRUS REACTIVATION;

EID: 0032830917     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-199909020-00035     Document Type: Article

References (25)

1. Monheit, G. D. Facial resurfacing may trigger the herpes simplex virus. Cosmetic Dermatol. 8: 9, 1995.
2. Goldman, M. P. Managing Complications of Laser Skin Resurfacing. In D. Scarborough and E. Bisacchia (Lds.), Strategies for Success in Laser Resurfacing. Beachwood, Ohio: Current Therapeutics Inc., 1998. Pp. 8-12.
3. Perkins, S. W., and Sklarew, E. C. Prevention of facial herpetic infections after chemical peel and dermabrasion: New treatment strategies in the prophylaxis of patients undergoing procedures of the perioral area. Plast. Reconstr. Surg. 98: 427, 1996.
4. Apfelberg, D. B. Perioperative considerations in laser resurfacing. Int. J. Aesthetic Restorat. Surg. 5: 21, 1997.
5. Wall, S. H., Ramey, S. J., Wall, F. P., et al. Anti-viral Prophylaxis in Laser Resurfacing Procedures. Abstract # SE.21. In Program and Abstracts. The 1998 Global Summit on Aesthetic Surgery, Los Angeles, Calif., May 1-6, 1998.
6. Spruance, S. L. The natural history of recurrent oral-facial herpes simplex virus infection. Semin. Dermatol. 11: 200, 1992.
7. Higgins, C. R., Schofield, J. K., Tatnall, F. M., et al. Natural history, management and complications of herpes labialis. J. Med. Virol. Suppl. 1: 22, 1993.
8. Straus, S. E., Rooney, J. F., Sever, J. L., et al. Herpes simplex virus infection: Biology, treatment, and prevention. Ann. Intern. Med. 103: 404, 1985.
9. Achauer, B. M. Lasers in plastic surgery: Current practice. Plast. Reconstr. Surg. 99: 1442, 1997.
10. Hruza, G. J. Skin resurfacing with lasers. Fitzpatrick's J. Clin. Dermatol. 3: 38, 1995.
11. The Medical Letter. Drugs for non-HIV viral infections. Med. Lett. Drugs Ther. 39: 69, 1997.
12. Vere Hodge, R. A. Famciclovir and penciclovir: The mode of action of famciclovir including its conversion to penciclovir. Antiviral Chem. Chemother. 4: 67, 1993.
13. Crumpacker, C. The pharmacological profile of famciclovir. Semin. Dermatol. 15: (Suppl 1): 14, 1996.
14. Weller, S., Blum, M. R., Doucette, M., et al. Pharmacokinetics of the acyclovir pro-drug valacyclovir after escalating single-and multiple-dose administration to normal volunteers. Clin. Pharmacol. Ther. 54: 595, 1993.
15. Mertz, G. J., Loveless, M. O., Levin, M. J., et al. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women: A multicenter, double-blind, placebo-controlled trial. Arch. Intern. Med. 157: 343, 1997.
16. Pue, M. A., and Benet, L. Z. Pharmacokinetics of famciclovir in man. Antiviral Chem. Chemother. 4 (Suppl 1): 47, 1993.
17. Medical Economics Data. Famvir. In Physician's Desk Reference, 52nd Ed. Montvale, N.J.: Medical Economics Data, 1998. P. 2824.
18. Wagstaff, A. J., Faulds, D., and Goa, K. L. Aciclovir: A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 47: 153, 1994.
19. Boyd, M. R., Bacon, T. H., Sutton, D., et al. Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut1-yl) guanine (BRL 39123) in cell culture. Antimicrob. Agents Chemother. 31: 1238, 1987.
20. Stuzin, J. M., Baker, T. J., Gordon, H. L., et al. Prevention of facial herpetic infections after chemical peel and dermabrasion: New treatment strategies in the prophylaxis of patients undergoing procedures of the perioral area (Discussion). Plast. Reconstr. Surg 98: 434, 1996.
21. Lask, G., Keller, G., Lowe, N., et al. Laser skin resurfacing with the Silktouch Flashscanner for facial rhytides. Dermatol Surg. 21: 1021, 1995.
22. Waldorf, H. A., Kauvar, A. N. B., and Geronemus, R.G. Skin resurfacing of fine to deep rhytides using a charfree carbon dioxide laser in 47 patients. Dermatol. Surg. 21: 940, 1995.
23. Sacks, S. L., Aoki, F. Y., Diaz-Mitoma, F., et al. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes: A randomized, double-blind multicenter trial. J.A.M.A. 276: 44, 1996.
24. Nanni, C. A., and Alster, T. S. Complications of carbon dioxide laser resurfacing: An evaluation of 500 patients. Dermatol. Surg. 24: 315, 1998.
25. Ramirez, O. M., and Pozner, J. N. Laser resurfacing as an adjunct to endoforehead lift, endofacelift, and biplanar facelift. Ann. Plast. Surg. 38: 315, 1997.